Gursimran Kochhar

Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium

Neeraj Narula, Farhad Peerani, Joseph Meserve et al. · The American Journal of Gastroenterology · 2018 · 175 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease

Parambir S. Dulai, Brigid S. Boland, Siddharth Singh et al. · Gastroenterology · 2018 · 149 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +14

Risk of Severe Coronavirus Disease 2019 in Patients With Inflammatory Bowel Disease in the United States: A Multicenter Research Network Study

Shailendra Singh, Ahmad Khan, Monica Chowdhry et al. · Gastroenterology · 2020 · 121 citations · Full text

Veterinary Medicine, Infectious Diseases, Epidemiology +10

Severe disease on endoscopy and steroid use increase the risk for bowel perforation during colonoscopy in inflammatory bowel disease patients

Udayakumar Navaneethan, Gursimran Kochhar, Hardeep Phull et al. · Journal of Crohn s and Colitis · 2011 · 95 citations · Full text

Medicine, Surgery, Gastroenterology +10

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

Joseph Meserve, Satimai Aniwan, Jenna L. Koliani‐Pace et al. · Clinical Gastroenterology and Hepatology · 2018 · 83 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16